Vaccinex (VCNX) Institutional Ownership $6.72 -0.18 (-2.61%) (As of 07/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Vaccinex (NASDAQ:VCNX)CurrentInstitutional OwnershipPercentage50.11%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$19.91MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$7.28M Get VCNX Insider Trade Alerts Want to know when executives and insiders are buying or selling Vaccinex stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VCNX Institutional Buying and Selling by Quarter Ad DTIHeard about the 72-Hour Profit Surge? Read this…One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…Click here now to get all the details. Vaccinex Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/12/2024AIGH Capital Management LLC817,061$543K0.2%-25.1%6.542% 2/9/2024Worth Venture Partners LLC654,079$435K0.2%-8.8%5.237% 11/15/2023Worth Venture Partners LLC717,559$811K0.5%+417.0%16.308% 11/15/2023Armistice Capital LLC680,000$768K0.0%N/A15.455% 11/13/2023AIGH Capital Management LLC1,090,173$1.23M0.6%-19.4%24.777% 5/15/2023AIGH Capital Management LLC951,801$380K0.1%-61.2%1.735% Get the Latest News and Ratings for VCNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. 5/1/2023Virtu Financial LLC103,898$42K0.0%N/A0.189% 2/16/2023AIGH Capital Management LLC2,451,801$1.66M0.5%+17.8%4.915% 5/12/2022AIGH Capital Management LLC2,081,801$2.63M0.6%N/A4.880% 11/16/2021Telemetry Investments L.L.C.132,500$286K0.4%+10.4%0.430% 11/15/2021Natixis31,895$69K0.0%N/A0.104% 11/12/2021Oppenheimer & Co. Inc.31,751$69K0.0%-24.3%0.103% 9/17/2021Virtu Financial LLC38,026$106K0.0%+103.9%0.123% 8/16/2021Point72 Asset Management L.P.395,522$1.11M0.0%N/A1.390% 8/16/2021Telemetry Investments L.L.C.120,000$336K0.5%+14.3%0.422% 8/16/2021State Street Corp67,200$188K0.0%N/A0.236% 8/13/2021Geode Capital Management LLC104,114$291K0.0%+59.4%0.366% 8/13/2021Vanguard Group Inc.600,624$1.68M0.0%+145.9%2.111% 5/19/2021Virtu Financial LLC18,652$56K0.0%N/A0.066% 5/17/2021Goldman Sachs Group Inc.20,447$61K0.0%-41.9%0.072% 5/13/2021 Bank of New York Mellon Corp17,954$54K0.0%N/A0.063% 5/12/2021Geode Capital Management LLC65,331$194K0.0%N/A0.230% 5/12/2021UBS Group AG28,708$86K0.0%N/A0.101% 5/10/2021Oppenheimer & Co. Inc.42,951$128K0.0%-24.3%0.151% 5/4/2021 Institute for Wealth Management LLC.20,000$60K0.0%N/A0.070% 2/17/2021Tacita Capital Inc13,574$28K0.0%N/A0.061% 2/16/2021Squarepoint Ops LLC40,583$84K0.0%N/A0.181% 2/11/2021Oppenheimer & Co. Inc.56,751$117K0.0%+141.1%0.254% 12/11/2020Virtu Financial LLC26,249$47K0.0%N/A0.117% 10/20/2020Wedbush Securities Inc.31,000$55K0.0%N/A0.154% (Data available from 1/1/2016 forward) VCNX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VCNX shares? During the previous two years, the following institutional investors and hedge funds held shares of Vaccinex shares: Armistice Capital LLC ($768K), AIGH Capital Management LLC ($543K), and Worth Venture Partners LLC ($435K), Virtu Financial LLC ($42K).Learn more on VCNX's institutional investors. What percentage of Vaccinex stock is owned by institutional investors? 50.11% of Vaccinex stock is owned by institutional investors. Learn more on VCNX's institutional investor holdings. Which institutional investors have been buying Vaccinex stock? The following institutional investors have purchased Vaccinex stock in the last 24 months: Armistice Capital LLC ($680K), Worth Venture Partners LLC ($578.76K), AIGH Capital Management LLC ($370K), and Virtu Financial LLC ($103.90K). How much institutional buying is happening at Vaccinex? Institutional investors have bought a total of 1,732,662 shares in the last 24 months. This purchase volume represents approximately $78.71M in transactions. Which Vaccinex major shareholders have been selling company stock? The following institutional investors have sold Vaccinex stock in the last 24 months: AIGH Capital Management LLC ($2.04M), and Worth Venture Partners LLC ($63.48K). How much institutional selling is happening at Vaccinex? Institutional investors have sold a total of 2,098,989 shares in the last 24 months. This volume of shares sold represents approximately $133.13M in transactions. Related Companies: CPIX Institutional Ownership NXTC Institutional Ownership YS Institutional Ownership BTAI Institutional Ownership MRKR Institutional Ownership CALC Institutional Ownership TPST Institutional Ownership PMN Institutional Ownership AADI Institutional Ownership MIRA Institutional Ownership This page (NASDAQ:VCNX) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.